Home › Funds › Connor, Clark & Lunn Investment Management Ltd. › AZN

Connor, Clark & Lunn Investment Management Ltd. position in AZN

ASTRAZENECA PLC · Health Care

Connor, Clark & Lunn Investment Management Ltd. reported holding 1,762,331 shares of AZN (ASTRAZENECA PLC) in its Q3 2026 13F filing — a position valued at US$284.6M, representing 0.50% of its reported portfolio and ranking #37 among its reported holdings. Connor, Clark & Lunn Investment Management Ltd. has disclosed AZN holdings in 11 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.76M sh
Reported value held$284.56M
Portfolio Weight0.50%
First reportedQ3 2023
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Connor, Clark & Lunn Investment Management Ltd.'s AZN position evolved

Connor, Clark & Lunn Investment Management Ltd. first disclosed a stake in AZN in Q3 2023 at 11,420 shares (US$773K). The position peaked in Q3 2026 at 1,762,331 shares, worth US$284.6M. Across 11 filings, Connor, Clark & Lunn Investment Management Ltd. increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,762,331 shares valued at US$284.6M. Notable position changes include a 42% increase in Q4 2024 (shares rose 14% over the following quarter), a 104% increase in Q3 2025 (shares rose 20% over the following quarter), a 3300% increase in Q4 2025 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 11.42K $773.36K New
Q4 2023 10.19K $686.30K Reduce
Q1 2024 9.96K $674.86K Reduce
Q2 2024 12.79K $997.34K Add
Q3 2024 17.81K $1.39M Add
Q4 2024 25.27K $1.66M Add
Q1 2025 31.08K $2.28M Add
Q2 2025 20.50K $1.43M Reduce
Q3 2025 41.81K $3.21M Add
Q4 2025 1.42M $130.70M Add
Q3 2026 1.76M $284.56M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AZN and 13F data

AZN (ASTRAZENECA PLC) is a Health Care company. 65 other funds we track also report a position in AZN — the largest reported positions include INVESTOR AB (US$9.78B), Norges Bank Investment Management (US$6.33B), Capital World Investors (US$5.63B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AZN

All AZN fund holders →

FAQ

How long has Connor, Clark & Lunn Investment Management Ltd. held AZN?

Connor, Clark & Lunn Investment Management Ltd. has disclosed AZN holdings in 11 of the last 13 reported quarters, going back to Q3 2023.

What is Connor, Clark & Lunn Investment Management Ltd.'s current position in AZN?

As of Q3 2026, Connor, Clark & Lunn Investment Management Ltd. holds 1.76M shares of AZN (ASTRAZENECA PLC), valued at $284.56M, representing 0.50% of its reported portfolio and ranking #37.

Has Connor, Clark & Lunn Investment Management Ltd. been buying or selling AZN?

In the latest 13F filing (Q3 2026), Connor, Clark & Lunn Investment Management Ltd. newly opened its position in AZN. The position peaked in Q3 2026 at 1.76M shares.

Which other funds hold AZN?

Other major institutional holders of AZN include INVESTOR AB, Norges Bank Investment Management, Capital World Investors, among 65 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.